{"transactions":[{"id":2833976,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":11867,"kind":"person","name":"HENDERSON REBECCA M","position":1,"cik":"0001254748","reported_name":"HENDERSON REBECCA M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right-to-buy)","published_at":"2021-02-26T00:35:26.000Z","date":"2021-02-23","kind":"exercise","acquired":false,"shares":3046,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that became exercisable on May 3, 2018."}],"balance_after":0,"derivative":{"exercise_price":160.28,"expiration_date":"2027-05-02","underlying":"Common Stock","underlying_shares":3046},"source":{"system":"sec-edgar","filing":"0001567619-21-004966","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761921004966/doc1.xml","form_type":"4"}},{"id":2833975,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":11867,"kind":"person","name":"HENDERSON REBECCA M","position":1,"cik":"0001254748","reported_name":"HENDERSON REBECCA M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-26T00:35:26.000Z","date":"2021-02-23","kind":"sale","acquired":false,"shares":3046,"price":513.4076,"value":1563839.5496,"ownership":{"direct":true},"balance_after":14696,"source":{"system":"sec-edgar","filing":"0001567619-21-004966","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761921004966/doc1.xml","form_type":"4"}},{"id":2833974,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":11867,"kind":"person","name":"HENDERSON REBECCA M","position":1,"cik":"0001254748","reported_name":"HENDERSON REBECCA M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-26T00:35:26.000Z","date":"2021-02-23","kind":"exercise","acquired":true,"shares":3046,"price":160.28,"value":488212.88,"ownership":{"direct":true},"balance_after":17742,"source":{"system":"sec-edgar","filing":"0001567619-21-004966","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761921004966/doc1.xml","form_type":"4"}},{"id":2984988,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":11867,"kind":"person","name":"HENDERSON REBECCA M","position":1,"cik":"0001254748","reported_name":"HENDERSON REBECCA M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right-to-buy)","published_at":"2020-11-12T22:01:20.000Z","date":"2020-11-10","kind":"exercise","acquired":false,"shares":5902,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that became exercisable on May 4, 2017."}],"balance_after":0,"derivative":{"exercise_price":85,"expiration_date":"2026-05-03","underlying":"Common Stock","underlying_shares":5902},"source":{"system":"sec-edgar","filing":"0001567619-20-019312","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761920019312/doc1.xml","form_type":"4"}},{"id":2984987,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":11867,"kind":"person","name":"HENDERSON REBECCA M","position":1,"cik":"0001254748","reported_name":"HENDERSON REBECCA M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-11-12T22:01:20.000Z","date":"2020-11-10","kind":"sale","acquired":false,"shares":5857,"price":435.9101,"value":2553125.4557,"ownership":{"direct":true},"balance_after":14696,"source":{"system":"sec-edgar","filing":"0001567619-20-019312","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761920019312/doc1.xml","form_type":"4"}},{"id":2984986,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":11867,"kind":"person","name":"HENDERSON REBECCA M","position":1,"cik":"0001254748","reported_name":"HENDERSON REBECCA M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-11-12T22:01:20.000Z","date":"2020-11-10","kind":"sale","acquired":false,"shares":45,"price":435.92,"value":19616.4,"ownership":{"direct":true},"balance_after":20553,"source":{"system":"sec-edgar","filing":"0001567619-20-019312","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761920019312/doc1.xml","form_type":"4"}},{"id":2984985,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":11867,"kind":"person","name":"HENDERSON REBECCA M","position":1,"cik":"0001254748","reported_name":"HENDERSON REBECCA M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-11-12T22:01:20.000Z","date":"2020-11-10","kind":"exercise","acquired":true,"shares":5902,"price":85,"value":501670.0,"ownership":{"direct":true},"balance_after":20598,"source":{"system":"sec-edgar","filing":"0001567619-20-019312","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761920019312/doc1.xml","form_type":"4"}},{"id":3147984,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":11867,"kind":"person","name":"HENDERSON REBECCA M","position":1,"cik":"0001254748","reported_name":"HENDERSON REBECCA M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right-to-buy)","published_at":"2020-05-15T21:03:08.000Z","date":"2020-05-13","kind":"exercise","acquired":false,"shares":7422,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Not spplicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that became exercisable as to 3,861 shares on May 6, 2016, without giving effect to the Stock Split.  The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect the Stock Split."}],"balance_after":300,"derivative":{"exercise_price":63.95,"expiration_date":"2025-05-05","underlying":"Common Stock","underlying_shares":7422},"source":{"system":"sec-edgar","filing":"0001567619-20-010595","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761920010595/doc1.xml","form_type":"4"}},{"id":3147983,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":11867,"kind":"person","name":"HENDERSON REBECCA M","position":1,"cik":"0001254748","reported_name":"HENDERSON REBECCA M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right-to-buy)","published_at":"2020-05-15T21:03:08.000Z","date":"2020-05-13","kind":"exercise","acquired":false,"shares":5974,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Not spplicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that became exercisable as to 2,987 shares on May 7, 2015, without giving effect to the 2-for-1 stock split of IDEXX Laboratories, Inc. common stock that occurred on June 15, 2015 (the \"Stock Split\").  The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect the Stock Split."}],"balance_after":0,"derivative":{"exercise_price":64.69,"expiration_date":"2024-05-06","underlying":"Common Stock","underlying_shares":5974},"source":{"system":"sec-edgar","filing":"0001567619-20-010595","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761920010595/doc1.xml","form_type":"4"}},{"id":3147982,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":11867,"kind":"person","name":"HENDERSON REBECCA M","position":1,"cik":"0001254748","reported_name":"HENDERSON REBECCA M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-15T21:03:08.000Z","date":"2020-05-13","kind":"sale","acquired":false,"shares":7422,"price":286.6566,"value":2127565.2852,"ownership":{"direct":true},"balance_after":14696,"source":{"system":"sec-edgar","filing":"0001567619-20-010595","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761920010595/doc1.xml","form_type":"4"}},{"id":3147981,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":11867,"kind":"person","name":"HENDERSON REBECCA M","position":1,"cik":"0001254748","reported_name":"HENDERSON REBECCA M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-15T21:03:08.000Z","date":"2020-05-13","kind":"exercise","acquired":true,"shares":7422,"price":63.95,"value":474636.9,"ownership":{"direct":true},"balance_after":22118,"source":{"system":"sec-edgar","filing":"0001567619-20-010595","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761920010595/doc1.xml","form_type":"4"}},{"id":3147980,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":11867,"kind":"person","name":"HENDERSON REBECCA M","position":1,"cik":"0001254748","reported_name":"HENDERSON REBECCA M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-15T21:03:08.000Z","date":"2020-05-13","kind":"sale","acquired":false,"shares":5974,"price":286.6566,"value":1712486.5284,"ownership":{"direct":true},"balance_after":14696,"source":{"system":"sec-edgar","filing":"0001567619-20-010595","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761920010595/doc1.xml","form_type":"4"}},{"id":3147979,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":11867,"kind":"person","name":"HENDERSON REBECCA M","position":1,"cik":"0001254748","reported_name":"HENDERSON REBECCA M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-15T21:03:08.000Z","date":"2020-05-13","kind":"exercise","acquired":true,"shares":5974,"price":64.69,"value":386458.06,"ownership":{"direct":true},"balance_after":20670,"source":{"system":"sec-edgar","filing":"0001567619-20-010595","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761920010595/doc1.xml","form_type":"4"}},{"id":3157149,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":11867,"kind":"person","name":"HENDERSON REBECCA M","position":1,"cik":"0001254748","reported_name":"HENDERSON REBECCA M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right-to-buy)","published_at":"2020-05-08T21:02:01.000Z","date":"2020-05-06","kind":"grant","acquired":true,"shares":1279,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vest in one installment on the one year anniversary of the date of grant or on the date of the 2021 annual meeting of shareholders, whichever event is earlier."}],"balance_after":1279,"derivative":{"exercise_price":283.59,"expiration_date":"2030-05-05","underlying":"Common Stock","underlying_shares":1279},"source":{"system":"sec-edgar","filing":"0001567619-20-009375","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761920009375/doc1.xml","form_type":"4"}},{"id":3157148,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":11867,"kind":"person","name":"HENDERSON REBECCA M","position":1,"cik":"0001254748","reported_name":"HENDERSON REBECCA M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Unit","published_at":"2020-05-08T21:02:01.000Z","date":"2020-05-06","kind":"grant","acquired":true,"shares":370,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock.  Deferred stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2021 annual meeting of shareholders, whichever event is earlier, and are payable as common stock one year following the Director's resignation from the Board of Directors."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock.  Deferred stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2021 annual meeting of shareholders, whichever event is earlier, and are payable as common stock one year following the Director's resignation from the Board of Directors."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock.  Deferred stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2021 annual meeting of shareholders, whichever event is earlier, and are payable as common stock one year following the Director's resignation from the Board of Directors."}],"balance_after":18115,"derivative":{"underlying":"Common Stock","underlying_shares":370},"source":{"system":"sec-edgar","filing":"0001567619-20-009375","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761920009375/doc1.xml","form_type":"4"}},{"id":104975,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11867,"kind":"person","name":"HENDERSON REBECCA M","position":1,"cik":"0001254748","reported_name":"HENDERSON REBECCA M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-05-08T00:41:23.000Z","date":"2020-05-05","kind":"grant","acquired":true,"shares":968.6942,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan (the Director Program) and vested immediately.  Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis.  Vested RSUs may be deferred by the director, in which case, payment will occur according to the elected deferral schedule."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 1,849 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan, and subject to a qualifying dividend reinvestment plan.  DEs are credited on the director's vested but deferred RSUs and are paid out in shares of the Company's Common Stock on a one-to-one basis along with a cash payment for any remaining fractional share amount."}],"balance_after":17973.6942,"source":{"system":"sec-edgar","filing":"0001127602-20-015852","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760220015852/form4.xml","form_type":"4"}},{"id":3433642,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":11867,"kind":"person","name":"HENDERSON REBECCA M","position":1,"cik":"0001254748","reported_name":"HENDERSON REBECCA M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-08-20T21:01:12.000Z","date":"2019-08-14","kind":"sale","acquired":false,"shares":4000,"price":271.1715,"value":1084686.0,"ownership":{"direct":true},"balance_after":14696,"source":{"system":"sec-edgar","filing":"0001567619-19-017356","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761919017356/doc1.xml","form_type":"4"}},{"id":3526843,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":11867,"kind":"person","name":"HENDERSON REBECCA M","position":1,"cik":"0001254748","reported_name":"HENDERSON REBECCA M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right-to-buy)","published_at":"2019-05-15T21:29:35.000Z","date":"2019-05-13","kind":"exercise","acquired":false,"shares":8790,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that became exercisable as to 4,395 shares on May 8, 2014, without giving effect to the 2-for-1 stock split of IDEXX Laboratories, Inc. common stock that occurred on June 15, 2015 (the \"Stock Split\").  The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect the Stock Split."}],"balance_after":0,"derivative":{"exercise_price":43.68,"expiration_date":"2023-05-07","underlying":"Common Stock","underlying_shares":8790},"source":{"system":"sec-edgar","filing":"0001567619-19-011316","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761919011316/doc1.xml","form_type":"4"}},{"id":3526842,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":11867,"kind":"person","name":"HENDERSON REBECCA M","position":1,"cik":"0001254748","reported_name":"HENDERSON REBECCA M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-15T21:29:35.000Z","date":"2019-05-13","kind":"sale","acquired":false,"shares":8790,"price":241.5725,"value":2123422.275,"ownership":{"direct":true},"balance_after":18696,"source":{"system":"sec-edgar","filing":"0001567619-19-011316","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761919011316/doc1.xml","form_type":"4"}},{"id":3526841,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":11867,"kind":"person","name":"HENDERSON REBECCA M","position":1,"cik":"0001254748","reported_name":"HENDERSON REBECCA M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-15T21:29:35.000Z","date":"2019-05-13","kind":"exercise","acquired":true,"shares":8790,"price":43.68,"value":383947.2,"ownership":{"direct":true},"balance_after":27486,"source":{"system":"sec-edgar","filing":"0001567619-19-011316","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761919011316/doc1.xml","form_type":"4"}},{"id":3532394,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":11867,"kind":"person","name":"HENDERSON REBECCA M","position":1,"cik":"0001254748","reported_name":"HENDERSON REBECCA M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right-to-buy)","published_at":"2019-05-10T21:20:51.000Z","date":"2019-05-08","kind":"grant","acquired":true,"shares":1404,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vest in one installment on the one year anniversary of the date of grant or on the date of the 2020 annual meeting of shareholders, whichever event is earlier."}],"balance_after":1404,"derivative":{"exercise_price":245.79,"expiration_date":"2029-05-07","underlying":"Common Stock","underlying_shares":1404},"source":{"system":"sec-edgar","filing":"0001567619-19-010452","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761919010452/doc1.xml","form_type":"4"}},{"id":3532393,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":11867,"kind":"person","name":"HENDERSON REBECCA M","position":1,"cik":"0001254748","reported_name":"HENDERSON REBECCA M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Unit","published_at":"2019-05-10T21:20:51.000Z","date":"2019-05-08","kind":"grant","acquired":true,"shares":427,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock.  Deferred stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2020 annual meeting of shareholders, whichever event is earlier, and are payable as common stock one year following the Director's resignation from the Board of Directors."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock.  Deferred stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2020 annual meeting of shareholders, whichever event is earlier, and are payable as common stock one year following the Director's resignation from the Board of Directors."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock.  Deferred stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2020 annual meeting of shareholders, whichever event is earlier, and are payable as common stock one year following the Director's resignation from the Board of Directors."}],"balance_after":17745,"derivative":{"underlying":"Common Stock","underlying_shares":427},"source":{"system":"sec-edgar","filing":"0001567619-19-010452","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761919010452/doc1.xml","form_type":"4"}},{"id":116904,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11867,"kind":"person","name":"HENDERSON REBECCA M","position":1,"cik":"0001254748","reported_name":"HENDERSON REBECCA M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-05-07T22:22:20.000Z","date":"2019-05-03","kind":"grant","acquired":true,"shares":1127,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan (the Director Program) and vested immediately.  Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis.  Vested RSUs may be deferred by the director, in which case, payment will occur according to the elected deferral schedule."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 1,454 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan, and subject to a qualifying dividend reinvestment plan.  DEs are credited on the director's vested but deferred RSUs and are paid out in shares of the Company's Common Stock on a one-to-one basis along with a cash payment for any remaining fractional share amount."}],"balance_after":16610,"source":{"system":"sec-edgar","filing":"0001127602-19-017639","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760219017639/form4.xml","form_type":"4"}},{"id":3749796,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":11867,"kind":"person","name":"HENDERSON REBECCA M","position":1,"cik":"0001254748","reported_name":"HENDERSON REBECCA M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right-to-buy)","published_at":"2018-11-29T22:02:31.000Z","date":"2018-11-27","kind":"exercise","acquired":false,"shares":7504,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that became exercisable as to 3,752 shares on May 9, 2013, without giving effect to the 2-for-1 stock split of IDEXX Laboratories, Inc. common stock that occurred on June 15, 2015 (the \"Stock Split\").  The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect the Stock Split."}],"balance_after":0,"derivative":{"exercise_price":22.0225,"expiration_date":"2019-05-09","underlying":"Common Stock","underlying_shares":7504},"source":{"system":"sec-edgar","filing":"0001567619-18-007117","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761918007117/doc1.xml","form_type":"4"}},{"id":3749795,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":11867,"kind":"person","name":"HENDERSON REBECCA M","position":1,"cik":"0001254748","reported_name":"HENDERSON REBECCA M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-11-29T22:02:31.000Z","date":"2018-11-27","kind":"sale","acquired":false,"shares":3504,"price":194.9178,"value":682991.9712,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average sales price of the shares sold ranging from a low of $194.7810 to a high of $194.9701 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":18696,"source":{"system":"sec-edgar","filing":"0001567619-18-007117","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761918007117/doc1.xml","form_type":"4"}},{"id":3749794,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":11867,"kind":"person","name":"HENDERSON REBECCA M","position":1,"cik":"0001254748","reported_name":"HENDERSON REBECCA M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-11-29T22:02:31.000Z","date":"2018-11-27","kind":"exercise","acquired":true,"shares":7504,"price":22.0225,"value":165256.84,"ownership":{"direct":true},"balance_after":22200,"source":{"system":"sec-edgar","filing":"0001567619-18-007117","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761918007117/doc1.xml","form_type":"4"}},{"id":125636,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11867,"kind":"person","name":"HENDERSON REBECCA M","position":1,"cik":"0001254748","reported_name":"HENDERSON REBECCA M","relationship":{"director":true}}],"security":"Nqso (Right to Buy)","published_at":"2018-08-15T00:29:53.000Z","date":"2018-08-10","kind":"exercise","acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":63.11,"exercise_date":"2010-07-30","expiration_date":"2019-07-30","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001127602-18-025351","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760218025351/form4.xml","form_type":"4"}},{"id":125635,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11867,"kind":"person","name":"HENDERSON REBECCA M","position":1,"cik":"0001254748","reported_name":"HENDERSON REBECCA M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-08-15T00:29:53.000Z","date":"2018-08-10","kind":"tax_withholding","acquired":false,"shares":977,"price":193.97,"value":189508.69,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Non-market exercise of 3,000 stock options expiring July 30, 2019 wherein 977 shares issuable pursuant to the exercise of these options were withheld by the Company to cover the option exercise price, with the remaining shares delivered to the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 1,191 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan, and subject to a qualifying dividend reinvestment plan.  DEs are credited on the director's vested but deferred RSUs and are paid out in shares of the Company's Common Stock on a one-to-one basis along with a cash payment for any remaining fractional share amount."}],"balance_after":15220,"source":{"system":"sec-edgar","filing":"0001127602-18-025351","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760218025351/form4.xml","form_type":"4"}},{"id":125634,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11867,"kind":"person","name":"HENDERSON REBECCA M","position":1,"cik":"0001254748","reported_name":"HENDERSON REBECCA M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-08-15T00:29:53.000Z","date":"2018-08-10","kind":"exercise","acquired":true,"shares":3000,"price":63.11,"value":189330.0,"ownership":{"direct":true},"balance_after":16197,"source":{"system":"sec-edgar","filing":"0001127602-18-025351","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760218025351/form4.xml","form_type":"4"}},{"id":3937904,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":11867,"kind":"person","name":"HENDERSON REBECCA M","position":1,"cik":"0001254748","reported_name":"HENDERSON REBECCA M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right-to-buy)","published_at":"2018-05-11T23:01:52.000Z","date":"2018-05-09","kind":"grant","acquired":true,"shares":2187,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vest in one installment on the one year anniversary of the date of grant or on the date of the 2019 annual meeting of shareholders, whichever event is earlier."}],"balance_after":2187,"derivative":{"exercise_price":206.62,"expiration_date":"2028-05-08","underlying":"Common Stock","underlying_shares":2187},"source":{"system":"sec-edgar","filing":"0001140361-18-023100","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/874716/000114036118023100/doc1.xml","form_type":"4"}},{"id":3937903,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":11867,"kind":"person","name":"HENDERSON REBECCA M","position":1,"cik":"0001254748","reported_name":"HENDERSON REBECCA M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Unit","published_at":"2018-05-11T23:01:52.000Z","date":"2018-05-09","kind":"grant","acquired":true,"shares":224,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock.  Deferred stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2019 annual meeting of shareholders, whichever event is earlier, and are payable as common stock one year following the Director's resignation from the Board of Directors."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock.  Deferred stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2019 annual meeting of shareholders, whichever event is earlier, and are payable as common stock one year following the Director's resignation from the Board of Directors."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock.  Deferred stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2019 annual meeting of shareholders, whichever event is earlier, and are payable as common stock one year following the Director's resignation from the Board of Directors."}],"balance_after":17318,"derivative":{"underlying":"Common Stock","underlying_shares":224},"source":{"system":"sec-edgar","filing":"0001140361-18-023100","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874716/000114036118023100/doc1.xml","form_type":"4"}},{"id":129454,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11867,"kind":"person","name":"HENDERSON REBECCA M","position":1,"cik":"0001254748","reported_name":"HENDERSON REBECCA M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-05-01T22:39:51.000Z","date":"2018-04-27","kind":"grant","acquired":true,"shares":1127,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan (the Director Program) and vested immediately.  Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis.  Vested RSUs may be deferred by the director, in which case, payment will occur according to the elected deferral schedule."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 1,105 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan.  DEs are credited on the director's vested but deferred RSUs and are paid out in shares of the Company's Common Stock on a one-to-one basis along with a cash payment for any remaining fractional share amount."}],"balance_after":13111,"source":{"system":"sec-edgar","filing":"0001127602-18-015812","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760218015812/form4.xml","form_type":"4"}},{"id":4224915,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":11867,"kind":"person","name":"HENDERSON REBECCA M","position":1,"cik":"0001254748","reported_name":"HENDERSON REBECCA M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-08-25T21:01:33.000Z","date":"2017-08-23","kind":"sale","acquired":false,"shares":2578,"price":153.7116,"value":396268.5048,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price of the shares sold ranging from a low of $153.71 to a high of $153.73 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":14696,"source":{"system":"sec-edgar","filing":"0001140361-17-033311","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/874716/000114036117033311/doc1.xml","form_type":"4"}},{"id":4224914,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":11867,"kind":"person","name":"HENDERSON REBECCA M","position":1,"cik":"0001254748","reported_name":"HENDERSON REBECCA M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-08-25T21:01:33.000Z","date":"2017-08-22","kind":"sale","acquired":false,"shares":2578,"price":152.8601,"value":394073.3378,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average sales price of the shares sold ranging from a low of $152.86 to a high of $152.861 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":17274,"source":{"system":"sec-edgar","filing":"0001140361-17-033311","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874716/000114036117033311/doc1.xml","form_type":"4"}},{"id":4332391,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":11867,"kind":"person","name":"HENDERSON REBECCA M","position":1,"cik":"0001254748","reported_name":"HENDERSON REBECCA M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right-to-buy)","published_at":"2017-05-05T22:11:09.000Z","date":"2017-05-04","kind":"exercise","acquired":false,"shares":6602,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that became exercisable as to 3,301 shares on February 14, 2012, without giving effect to the 2-for-1 stock split of IDEXX Laboratories, Inc. common stock that occurred on June 15, 2015 (the \"Stock Split\").? The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect the Stock Split."}],"balance_after":0,"derivative":{"exercise_price":38.795,"expiration_date":"2018-02-13","underlying":"Common Stock","underlying_shares":6602},"source":{"system":"sec-edgar","filing":"0001140361-17-018657","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/874716/000114036117018657/doc1.xml","form_type":"4"}},{"id":4332390,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":11867,"kind":"person","name":"HENDERSON REBECCA M","position":1,"cik":"0001254748","reported_name":"HENDERSON REBECCA M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right-to-buy)","published_at":"2017-05-05T22:11:09.000Z","date":"2017-05-03","kind":"grant","acquired":true,"shares":3046,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vest in one installment on May 3, 2018."}],"balance_after":3046,"derivative":{"exercise_price":160.28,"expiration_date":"2027-05-02","underlying":"Common Stock","underlying_shares":3046},"source":{"system":"sec-edgar","filing":"0001140361-17-018657","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/874716/000114036117018657/doc1.xml","form_type":"4"}},{"id":4332389,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":11867,"kind":"person","name":"HENDERSON REBECCA M","position":1,"cik":"0001254748","reported_name":"HENDERSON REBECCA M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Unit","published_at":"2017-05-05T22:11:09.000Z","date":"2017-05-03","kind":"grant","acquired":true,"shares":289,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock.  Deferred stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2018 annual meeting of stockholders, whichever event is earlier, and are payable as common stock one year following the Director's resignation from the Board of Directors."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock.  Deferred stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2018 annual meeting of stockholders, whichever event is earlier, and are payable as common stock one year following the Director's resignation from the Board of Directors."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock.  Deferred stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2018 annual meeting of stockholders, whichever event is earlier, and are payable as common stock one year following the Director's resignation from the Board of Directors."}],"balance_after":17094,"derivative":{"underlying":"Common Stock","underlying_shares":289},"source":{"system":"sec-edgar","filing":"0001140361-17-018657","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/874716/000114036117018657/doc1.xml","form_type":"4"}},{"id":4332388,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":11867,"kind":"person","name":"HENDERSON REBECCA M","position":1,"cik":"0001254748","reported_name":"HENDERSON REBECCA M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-05T22:11:09.000Z","date":"2017-05-04","kind":"sale","acquired":false,"shares":1700,"price":159.9485,"value":271912.45,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average sales price of the shares sold ranging from a low of $159.9110 to a high of $159.9718 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":19852,"source":{"system":"sec-edgar","filing":"0001140361-17-018657","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/874716/000114036117018657/doc1.xml","form_type":"4"}},{"id":4332387,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":11867,"kind":"person","name":"HENDERSON REBECCA M","position":1,"cik":"0001254748","reported_name":"HENDERSON REBECCA M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-05T22:11:09.000Z","date":"2017-05-04","kind":"exercise","acquired":true,"shares":6602,"price":38.795,"value":256124.59,"ownership":{"direct":true},"balance_after":21552,"source":{"system":"sec-edgar","filing":"0001140361-17-018657","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874716/000114036117018657/doc1.xml","form_type":"4"}},{"id":141001,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11867,"kind":"person","name":"HENDERSON REBECCA M","position":1,"cik":"0001254748","reported_name":"HENDERSON REBECCA M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2017-05-04T00:28:37.000Z","date":"2017-05-01","kind":"grant","acquired":true,"shares":1230,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan (the Director Program) and vested immediately.  Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis.  Vested RSUs may be deferred by the director, in which case, payment will occur according to the elected deferral schedule."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 786 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan.  DEs are credited on the director's vested but deferred RSUs and are paid out in shares of the Company's Common Stock on a one-to-one basis along with a cash payment for any remaining fractional share amount."}],"balance_after":11665,"source":{"system":"sec-edgar","filing":"0001127602-17-016735","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760217016735/form4.xml","form_type":"4"}},{"id":4401425,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":11867,"kind":"person","name":"HENDERSON REBECCA M","position":1,"cik":"0001254748","reported_name":"HENDERSON REBECCA M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-03-06T23:44:35.000Z","date":"2017-02-28","kind":"sale","acquired":false,"shares":300,"price":146,"value":43800.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sales price of the shares sold ranging from a low of $145.95 to a high of $146.14 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":14950,"source":{"system":"sec-edgar","filing":"0001140361-17-010774","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/874716/000114036117010774/doc1.xml","form_type":"4"}},{"id":4401424,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":11867,"kind":"person","name":"HENDERSON REBECCA M","position":1,"cik":"0001254748","reported_name":"HENDERSON REBECCA M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-03-06T23:44:35.000Z","date":"2017-02-28","kind":"sale","acquired":false,"shares":5500,"price":145.2305,"value":798767.75,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price of the shares sold ranging from a low of $144.91 to a high of $145.91 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":15250,"source":{"system":"sec-edgar","filing":"0001140361-17-010774","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/874716/000114036117010774/doc1.xml","form_type":"4"}},{"id":4401423,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":11867,"kind":"person","name":"HENDERSON REBECCA M","position":1,"cik":"0001254748","reported_name":"HENDERSON REBECCA M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-03-06T23:44:35.000Z","date":"2017-02-28","kind":"sale","acquired":false,"shares":700,"price":144.5042,"value":101152.94,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average sales price of the shares sold ranging from a low of $143.88 to a high of $144.87 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":20750,"source":{"system":"sec-edgar","filing":"0001140361-17-010774","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874716/000114036117010774/doc1.xml","form_type":"4"}},{"id":4401422,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":11867,"kind":"person","name":"HENDERSON REBECCA M","position":1,"cik":"0001254748","reported_name":"HENDERSON REBECCA M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right-to-buy)","published_at":"2017-03-06T23:41:36.000Z","date":"2016-08-25","kind":"exercise","acquired":false,"shares":9924,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that became exercisable as to 4,962 shares on February 14, 2011, without giving effect to the 2-for-1 stock split of IDEXX Laboratories, Inc. common stock that occurred on June 15, 2015 (the \"Stock Split\").  The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect the Stock Split."}],"balance_after":0,"derivative":{"exercise_price":26.655,"expiration_date":"2017-02-13","underlying":"Common Stock","underlying_shares":9924},"source":{"system":"sec-edgar","filing":"0001140361-17-010771","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/874716/000114036117010771/doc1.xml","form_type":"4/A","original_submission_date":"2016-08-26"}},{"id":4401421,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":11867,"kind":"person","name":"HENDERSON REBECCA M","position":1,"cik":"0001254748","reported_name":"HENDERSON REBECCA M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-03-06T23:41:36.000Z","date":"2016-08-25","kind":"sale","acquired":false,"shares":9924,"price":110.4346,"value":1095952.9704,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This Form 4 is being amended solely to correct the number of shares of common stock beneficially owned by the reporting person following the reported transactions on the date of the transactions."}],"balance_after":21450,"source":{"system":"sec-edgar","filing":"0001140361-17-010771","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/874716/000114036117010771/doc1.xml","form_type":"4/A","original_submission_date":"2016-08-26"}},{"id":4401420,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":11867,"kind":"person","name":"HENDERSON REBECCA M","position":1,"cik":"0001254748","reported_name":"HENDERSON REBECCA M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-03-06T23:41:36.000Z","date":"2016-08-25","kind":"exercise","acquired":true,"shares":9924,"price":26.655,"value":264524.22,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This Form 4 is being amended solely to correct the number of shares of common stock beneficially owned by the reporting person following the reported transactions on the date of the transactions."}],"balance_after":31374,"source":{"system":"sec-edgar","filing":"0001140361-17-010771","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874716/000114036117010771/doc1.xml","form_type":"4/A","original_submission_date":"2016-08-26"}},{"id":153072,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11867,"kind":"person","name":"HENDERSON REBECCA M","position":1,"cik":"0001254748","reported_name":"HENDERSON REBECCA M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2016-05-06T00:02:45.000Z","date":"2016-05-03","kind":"grant","acquired":true,"shares":1279,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan (the Director Program) and vested immediately.  Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis.  Vested RSUs may be deferred by the director, in which case, payment will occur according to the elected deferral schedule."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 522 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan.  DEs are credited on the director's vested but deferred RSUs and are paid out in shares of the Company's Common Stock on a one-to-one basis along with a cash payment for any remaining fractional share amount."}],"balance_after":10171,"source":{"system":"sec-edgar","filing":"0001127602-16-051279","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760216051279/form4.xml","form_type":"4"}},{"id":164488,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11867,"kind":"person","name":"HENDERSON REBECCA M","position":1,"cik":"0001254748","reported_name":"HENDERSON REBECCA M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2015-04-28T23:07:48.000Z","date":"2015-04-24","kind":"grant","acquired":true,"shares":1191,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan (the Director Program) and vested immediately.  Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis.  Vested RSUs may be deferred by the director, in which case, payment will occur according to the elected deferral schedule."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 328 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan.  DEs are credited on the director's vested but deferred RSUs and are paid out in shares of the Company's Common Stock on a one-to-one basis along with a cash payment for any remaining fractional share amount."}],"balance_after":8698,"source":{"system":"sec-edgar","filing":"0001127602-15-015454","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760215015454/form4.xml","form_type":"4"}},{"id":174326,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11867,"kind":"person","name":"HENDERSON REBECCA M","position":1,"cik":"0001254748","reported_name":"HENDERSON REBECCA M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2014-04-29T21:14:38.000Z","date":"2014-04-25","kind":"grant","acquired":true,"shares":1795,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan (the Director Program) and vested immediately.  Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis.  Vested RSUs may be deferred by the director, in which case, payment will occur according to the elected deferral schedule."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 193 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan.  DEs are credited on the director's vested but deferred RSUs and are paid out in shares of the Company's Common Stock on a one-to-one basis along with a cash payment for any remaining fractional share amount."}],"balance_after":7372,"source":{"system":"sec-edgar","filing":"0001127602-14-015488","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760214015488/form4.xml","form_type":"4"}},{"id":176454,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11867,"kind":"person","name":"HENDERSON REBECCA M","position":1,"cik":"0001254748","reported_name":"HENDERSON REBECCA M","relationship":{"director":true}}],"security":"Nqso (Right to Buy)","published_at":"2014-02-14T21:34:43.000Z","date":"2014-02-13","kind":"exercise","acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":58.43,"exercise_date":"2011-04-26","expiration_date":"2020-04-26","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001127602-14-006489","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760214006489/form4.xml","form_type":"4"}},{"id":176453,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11867,"kind":"person","name":"HENDERSON REBECCA M","position":1,"cik":"0001254748","reported_name":"HENDERSON REBECCA M","relationship":{"director":true}}],"security":"Nqso (Right to Buy)","published_at":"2014-02-14T21:34:43.000Z","date":"2014-02-13","kind":"exercise","acquired":false,"shares":17000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3000,"derivative":{"exercise_price":63.11,"exercise_date":"2010-07-30","expiration_date":"2019-07-30","underlying":"Common Stock","underlying_shares":17000},"source":{"system":"sec-edgar","filing":"0001127602-14-006489","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760214006489/form4.xml","form_type":"4"}},{"id":176452,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11867,"kind":"person","name":"HENDERSON REBECCA M","position":1,"cik":"0001254748","reported_name":"HENDERSON REBECCA M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2014-02-14T21:34:43.000Z","date":"2014-02-13","kind":"sale","acquired":false,"shares":20000,"price":123.534,"value":2470680.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is an average price.  The prices ranged from $123.26 to $123.78 per share.  Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC, the issuer or a security holder of the issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 165 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the director's vested but deferred Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis along with a cash payment for any remaining fractional share amount."}],"balance_after":5549,"source":{"system":"sec-edgar","filing":"0001127602-14-006489","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760214006489/form4.xml","form_type":"4"}},{"id":176451,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11867,"kind":"person","name":"HENDERSON REBECCA M","position":1,"cik":"0001254748","reported_name":"HENDERSON REBECCA M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2014-02-14T21:34:43.000Z","date":"2014-02-13","kind":"exercise","acquired":true,"shares":3000,"price":58.43,"value":175290.0,"ownership":{"direct":true},"balance_after":25549,"source":{"system":"sec-edgar","filing":"0001127602-14-006489","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760214006489/form4.xml","form_type":"4"}},{"id":176450,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11867,"kind":"person","name":"HENDERSON REBECCA M","position":1,"cik":"0001254748","reported_name":"HENDERSON REBECCA M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2014-02-14T21:34:43.000Z","date":"2014-02-13","kind":"exercise","acquired":true,"shares":17000,"price":63.11,"value":1072870.0,"ownership":{"direct":true},"balance_after":22549,"source":{"system":"sec-edgar","filing":"0001127602-14-006489","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760214006489/form4.xml","form_type":"4"}},{"id":183994,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11867,"kind":"person","name":"HENDERSON REBECCA M","position":1,"cik":"0001254748","reported_name":"HENDERSON REBECCA M","relationship":{"director":true}}],"security":"Nqso (Right to Buy)","published_at":"2013-05-20T23:15:54.000Z","date":"2013-05-17","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":54.69,"exercise_date":"2012-04-25","expiration_date":"2021-04-25","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001127602-13-017602","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760213017602/form4.xml","form_type":"4"}},{"id":183993,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11867,"kind":"person","name":"HENDERSON REBECCA M","position":1,"cik":"0001254748","reported_name":"HENDERSON REBECCA M","relationship":{"director":true}}],"security":"Nqso (Right to Buy)","published_at":"2013-05-20T23:15:54.000Z","date":"2013-05-17","kind":"exercise","acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3000,"derivative":{"exercise_price":58.43,"exercise_date":"2011-04-26","expiration_date":"2020-04-26","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001127602-13-017602","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760213017602/form4.xml","form_type":"4"}},{"id":183992,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11867,"kind":"person","name":"HENDERSON REBECCA M","position":1,"cik":"0001254748","reported_name":"HENDERSON REBECCA M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2013-05-20T23:15:54.000Z","date":"2013-05-17","kind":"sale","acquired":false,"shares":1421,"price":105.8441,"value":150404.4661,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is an average price.  The prices ranged from $105.8301 to $105.85 per share.  Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC, the issuer or a security holder of the issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"These shares include 93 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the director's vested but deferred Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis along with a cash payment for any remaining fractional share amount."}],"balance_after":5477,"source":{"system":"sec-edgar","filing":"0001127602-13-017602","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760213017602/form4.xml","form_type":"4"}},{"id":183991,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11867,"kind":"person","name":"HENDERSON REBECCA M","position":1,"cik":"0001254748","reported_name":"HENDERSON REBECCA M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2013-05-20T23:15:54.000Z","date":"2013-05-17","kind":"sale","acquired":false,"shares":7000,"price":105.6994,"value":739895.8,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is an average price.  The prices ranged from $105.67 to $105.75 per share.  Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC, the issuer or a security holder of the issuer."}],"balance_after":6898,"source":{"system":"sec-edgar","filing":"0001127602-13-017602","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760213017602/form4.xml","form_type":"4"}},{"id":183990,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11867,"kind":"person","name":"HENDERSON REBECCA M","position":1,"cik":"0001254748","reported_name":"HENDERSON REBECCA M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2013-05-20T23:15:54.000Z","date":"2013-05-17","kind":"exercise","acquired":true,"shares":5000,"price":54.69,"value":273450.0,"ownership":{"direct":true},"balance_after":13898,"source":{"system":"sec-edgar","filing":"0001127602-13-017602","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760213017602/form4.xml","form_type":"4"}},{"id":183989,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11867,"kind":"person","name":"HENDERSON REBECCA M","position":1,"cik":"0001254748","reported_name":"HENDERSON REBECCA M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2013-05-20T23:15:54.000Z","date":"2013-05-17","kind":"exercise","acquired":true,"shares":2000,"price":58.43,"value":116860.0,"ownership":{"direct":true},"balance_after":8898,"source":{"system":"sec-edgar","filing":"0001127602-13-017602","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760213017602/form4.xml","form_type":"4"}},{"id":184975,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11867,"kind":"person","name":"HENDERSON REBECCA M","position":1,"cik":"0001254748","reported_name":"HENDERSON REBECCA M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2013-04-30T21:55:07.000Z","date":"2013-04-26","kind":"grant","acquired":true,"shares":1845,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Equity Incentive Plan (the Director Program) and vested immediately.  Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis.  Vested RSUs may be deferred by the director, in which case, payment will occur according to the elected deferral schedule."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 93 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan.  DEs are credited on the director's unvested, and vested but deferred, RSUs and are paid out in shares of the Company's common stock on a one-to-one basis along with a cash payment for any remaining fractional share amount."}],"balance_after":6898,"source":{"system":"sec-edgar","filing":"0001127602-13-014799","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760213014799/form4.xml","form_type":"4"}},{"id":194032,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11867,"kind":"person","name":"HENDERSON REBECCA M","position":1,"cik":"0001254748","reported_name":"HENDERSON REBECCA M","relationship":{"director":true}}],"security":"Nqso (Right to Buy)","published_at":"2012-05-01T23:43:22.000Z","date":"2012-04-27","kind":"grant","acquired":true,"shares":5000,"price":71.64,"value":358200.0,"ownership":{"direct":true},"balance_after":5000,"derivative":{"exercise_price":71.64,"exercise_date":"2013-04-27","expiration_date":"2022-04-27","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001127602-12-015223","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760212015223/form4.xml","form_type":"4"}},{"id":194031,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11867,"kind":"person","name":"HENDERSON REBECCA M","position":1,"cik":"0001254748","reported_name":"HENDERSON REBECCA M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2012-05-01T23:43:22.000Z","date":"2012-04-27","kind":"grant","acquired":true,"shares":1395,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units (\"RSUs\") were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Equity Incentive Plan (the \"Director Program\") and will vest one year from the grant date because the director has less than three years of prior continuous service as a director. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case, payment will occur according to the elected deferral schedule."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 26 Dividend Equivalents (\"DEs\") granted pursuant to the Director Program.  The acquisition of DEs had previously been reported in Table II of the director's Form 4 filings prior to the Company implementing a qualifying dividend reinvestment plan in 2012. DEs are credited on the director's unvested, and vested but deferred, RSUs and are paid out in shares of the Company's common stock on a one-to-one basis along with a cash payment for any remaining fractional share amount."}],"balance_after":4960,"source":{"system":"sec-edgar","filing":"0001127602-12-015223","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760212015223/form4.xml","form_type":"4"}},{"id":197566,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11867,"kind":"person","name":"HENDERSON REBECCA M","position":1,"cik":"0001254748","reported_name":"HENDERSON REBECCA M","relationship":{"director":true}}],"security":"Dividend Equivalent","published_at":"2011-12-13T00:06:12.000Z","date":"2011-12-08","kind":"grant","acquired":true,"shares":8.2442,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Dividend Equivalents were granted pursuant to the Amgen Inc. 2009 Director Equity Incentive Program under the Amgen Inc. 2009 Equity Incentive Plan.  The Dividend Equivalents are credited and deemed reinvested in the director's account in lieu of a cash dividend payment on the director's vested but deferred Restricted Stock Units.  Dividend Equivalents will be paid in whole shares of the Company's common stock on a one-to-one basis on the director's elected deferral date, along with a cash payment for any remaining fractional share amount."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Dividend Equivalents were granted pursuant to the Amgen Inc. 2009 Director Equity Incentive Program under the Amgen Inc. 2009 Equity Incentive Plan.  The Dividend Equivalents are credited and deemed reinvested in the director's account in lieu of a cash dividend payment on the director's vested but deferred Restricted Stock Units.  Dividend Equivalents will be paid in whole shares of the Company's common stock on a one-to-one basis on the director's elected deferral date, along with a cash payment for any remaining fractional share amount."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Dividend Equivalents were granted pursuant to the Amgen Inc. 2009 Director Equity Incentive Program under the Amgen Inc. 2009 Equity Incentive Plan.  The Dividend Equivalents are credited and deemed reinvested in the director's account in lieu of a cash dividend payment on the director's vested but deferred Restricted Stock Units.  Dividend Equivalents will be paid in whole shares of the Company's common stock on a one-to-one basis on the director's elected deferral date, along with a cash payment for any remaining fractional share amount."}],"balance_after":16.9059,"derivative":{"underlying":"Common Stock","underlying_shares":8.2442},"source":{"system":"sec-edgar","filing":"0001127602-11-031951","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760211031951/form4.xml","form_type":"4"}},{"id":199538,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11867,"kind":"person","name":"HENDERSON REBECCA M","position":1,"cik":"0001254748","reported_name":"HENDERSON REBECCA M","relationship":{"director":true}}],"security":"Dividend Equivalent","published_at":"2011-09-12T21:11:11.000Z","date":"2011-09-08","kind":"grant","acquired":true,"shares":8.6617,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Dividend Equivalents were granted pursuant to the Amgen Inc. 2009 Director Equity Incentive Program under the Amgen Inc. 2009 Equity Incentive Plan.  The Dividend Equivalents are credited and deemed reinvested in the director's account in lieu of a cash dividend payment on the director's vested but deferred Restricted Stock Units.  Dividend Equivalents will be paid in whole shares of the Company's common stock on a one-to-one basis on the director's elected deferral date, along with a cash payment for any remaining fractional share amount."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Dividend Equivalents were granted pursuant to the Amgen Inc. 2009 Director Equity Incentive Program under the Amgen Inc. 2009 Equity Incentive Plan.  The Dividend Equivalents are credited and deemed reinvested in the director's account in lieu of a cash dividend payment on the director's vested but deferred Restricted Stock Units.  Dividend Equivalents will be paid in whole shares of the Company's common stock on a one-to-one basis on the director's elected deferral date, along with a cash payment for any remaining fractional share amount."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Dividend Equivalents were granted pursuant to the Amgen Inc. 2009 Director Equity Incentive Program under the Amgen Inc. 2009 Equity Incentive Plan.  The Dividend Equivalents are credited and deemed reinvested in the director's account in lieu of a cash dividend payment on the director's vested but deferred Restricted Stock Units.  Dividend Equivalents will be paid in whole shares of the Company's common stock on a one-to-one basis on the director's elected deferral date, along with a cash payment for any remaining fractional share amount."}],"balance_after":8.6617,"derivative":{"underlying":"Common Stock","underlying_shares":8.6617},"source":{"system":"sec-edgar","filing":"0001127602-11-025056","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760211025056/form4.xml","form_type":"4"}},{"id":203531,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11867,"kind":"person","name":"HENDERSON REBECCA M","position":1,"cik":"0001254748","reported_name":"HENDERSON REBECCA M","relationship":{"director":true}}],"security":"Nqso (Right to Buy)","published_at":"2011-04-28T00:12:16.000Z","date":"2011-04-25","kind":"grant","acquired":true,"shares":5000,"price":54.69,"value":273450.0,"ownership":{"direct":true},"balance_after":5000,"derivative":{"exercise_price":54.69,"exercise_date":"2012-04-25","expiration_date":"2021-04-25","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001127602-11-013856","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760211013856/form4.xml","form_type":"4"}},{"id":203530,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11867,"kind":"person","name":"HENDERSON REBECCA M","position":1,"cik":"0001254748","reported_name":"HENDERSON REBECCA M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2011-04-28T00:12:16.000Z","date":"2011-04-25","kind":"grant","acquired":true,"shares":1828,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Equity Incentive Program under the Amgen Inc. 2009 Equity Incentive Plan. RSUs vest (a) immediately for directors who have three years or more of prior continuous service as a director, or (b) one year from the grant date if the director has had less than three years of prior continuous service as a director. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis unless payment is otherwise deferred by the director."}],"balance_after":3539,"source":{"system":"sec-edgar","filing":"0001127602-11-013856","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760211013856/form4.xml","form_type":"4"}},{"id":214403,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11867,"kind":"person","name":"HENDERSON REBECCA M","position":1,"cik":"0001254748","reported_name":"HENDERSON REBECCA M","relationship":{"director":true}}],"security":"Nqso (Right to Buy)","published_at":"2010-04-28T23:04:34.000Z","date":"2010-04-26","kind":"grant","acquired":true,"shares":5000,"price":58.43,"value":292150.0,"ownership":{"direct":true},"balance_after":5000,"derivative":{"exercise_price":58.43,"exercise_date":"2011-04-26","expiration_date":"2020-04-26","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001127602-10-012370","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760210012370/form4.xml","form_type":"4"}},{"id":214402,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11867,"kind":"person","name":"HENDERSON REBECCA M","position":1,"cik":"0001254748","reported_name":"HENDERSON REBECCA M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2010-04-28T23:04:34.000Z","date":"2010-04-26","kind":"grant","acquired":true,"shares":1711,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. Director Equity Incentive Program under the Company's 2009 Equity Incentive Plan. RSUs vest (a) immediately for directors who have three years or more of prior continuous service as a director, or (b) one year from the grant date if the director has had less than three years of prior continuous service as a director. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis unless payment is otherwise deferred by the director."}],"balance_after":1711,"source":{"system":"sec-edgar","filing":"0001127602-10-012370","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760210012370/form4.xml","form_type":"4"}},{"id":223230,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11867,"kind":"person","name":"HENDERSON REBECCA M","position":1,"cik":"0001254748","reported_name":"HENDERSON REBECCA M","relationship":{"director":true}}],"security":"Nqso (Right to Buy)","published_at":"2009-07-31T16:07:47.000Z","date":"2009-07-30","kind":"grant","acquired":true,"shares":20000,"price":63.11,"value":1262200.0,"ownership":{"direct":true},"balance_after":20000,"derivative":{"exercise_price":63.11,"exercise_date":"2010-07-30","expiration_date":"2019-07-30","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001127602-09-016427","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760209016427/form4.xml","form_type":"4"}}]}